Advertisement
Canada markets close in 56 minutes
  • S&P/TSX

    22,208.90
    +101.82 (+0.46%)
     
  • S&P 500

    5,260.30
    +11.81 (+0.23%)
     
  • DOW

    39,830.77
    +70.69 (+0.18%)
     
  • CAD/USD

    0.7384
    +0.0012 (+0.16%)
     
  • CRUDE OIL

    83.01
    +1.66 (+2.04%)
     
  • Bitcoin CAD

    95,491.05
    +2,586.52 (+2.78%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,240.70
    +28.00 (+1.27%)
     
  • RUSSELL 2000

    2,122.31
    +7.96 (+0.38%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,405.03
    +5.51 (+0.03%)
     
  • VOLATILITY

    12.96
    +0.18 (+1.41%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6843
    +0.0038 (+0.56%)
     

The Gross Law Firm Announces Class Actions on Behalf of Shareholders of CYDY, NEPT and ACAD

NEW YORK, NY / ACCESSWIRE / May 6, 2021 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

CytoDyn Inc. (OTCQB:CYDY)

Investors Affected : March 27, 2020 - March 9, 2021

A class action has commenced on behalf of certain shareholders in CytoDyn Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: CytoDyn securities were actively traded over the counter (OTC) in the United States. While the exact number of Class members is unknown to Plaintiff at this time and can be ascertained only through appropriate discovery, Plaintiff believes that there are hundreds or thousands of members in the proposed Class. Record owners and other members of the Class may be identified from records maintained by CytoDyn or its transfer agent and/or OTC Markets and may be notified of the pendency of this action by mail, using the form of notice similar to that customarily used in securities class actions.

ADVERTISEMENT

Shareholders may find more information at https://securitiesclasslaw.com/securities/cytodyn-inc-loss-submission-form/?id=15563&from=1

Neptune Wellness Solutions Inc. (NASDAQ:NEPT)

Investors Affected : July 24, 2019 - February 16, 2021

A class action has commenced on behalf of certain shareholders in Neptune Wellness Solutions Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the cost of Neptune's integration of the assets and operations acquired in the SugarLeaf Acquisition would be larger than the Company had acknowledged, placing significant strain on the Company's capital reserves; (ii) accordingly, it was reasonably foreseeable that the company would need to conduct additional stock offerings to raise more capital; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/neptune-wellness-solutions-inc-loss-submission-form/?id=15563&from=1

Acadia Pharmaceuticals Inc. (NASDAQ:ACAD)

Investors Affected : June 15, 2020 - April 4, 2021

A class action has commenced on behalf of certain shareholders in Acadia Pharmaceuticals Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies; (ii) accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed; (iii) the FDA was unlikely to approve the pimavanserin sNDA in its present form; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/acadia-pharmaceuticals-inc-loss-submission-form/?id=15563&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm



View source version on accesswire.com:
https://www.accesswire.com/645377/The-Gross-Law-Firm-Announces-Class-Actions-on-Behalf-of-Shareholders-of-CYDY-NEPT-and-ACAD